Trends in stage-specific population-based survival of cancer
patients in the Czech Republic in the period 2000-2008

J 2014

Trends in stage-specific population-based survival of cancer patients in the Czech Republic in the period 2000-2008

PAVLÍK, Tomáš, Ondřej MÁJEK, Tomáš BÜCHLER, Rostislav VYZULA, Jiří PETERA et. al.

Basic information

Original name

Trends in stage-specific population-based survival of cancer patients in the Czech Republic in the period 2000-2008

Authors

PAVLÍK, Tomáš (203 Czech Republic, guarantor, belonging to the institution), Ondřej MÁJEK (203 Czech Republic, belonging to the institution), Tomáš BÜCHLER (703 Slovakia), Rostislav VYZULA (203 Czech Republic), Jiří PETERA (203 Czech Republic), Miroslav RYŠKA (203 Czech Republic), Aleš RYŠKA (203 Czech Republic), David CIBULA (203 Czech Republic), Marek BABJUK (203 Czech Republic), Jitka ABRAHAMOVÁ (203 Czech Republic), Jiří VORLÍČEK (203 Czech Republic), Jan MUŽÍK (203 Czech Republic, belonging to the institution) and Ladislav DUŠEK (203 Czech Republic, belonging to the institution)

Edition

Cancer epidemiology, Oxford, Elsevier, 2014, 1877-7821

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30200 3.2 Clinical medicine

Country of publisher

United Kingdom of Great Britain and Northern Ireland

Confidentiality degree

není předmětem státního či obchodního tajemství

Impact factor

Impact factor: 2.711

RIV identification code

RIV/00216224:14110/14:00075537

Organization unit

Faculty of Medicine

DOI

http://dx.doi.org/10.1016/j.canep.2013.11.002

UT WoS

000334029800005

Keywords in English

Cancer; Population-based registry; Relative survival; Stage-specific analysis

Abstract

V originále

Background: The objective of this study was to assess trends in overall and in stage-specific 5-year relative survival rates of the Czech cancer patients between periods 2000-2004 and 2005-2008. Methods: All Czech cancer patients diagnosed between 1995 and 2008 were included in the analysis. Period analysis was employed to calculate 5-year relative survival for 21 cancers. Results: Significant improvements in crude 5-year relative survival for 14 of 21 assessed types of cancer, including the most frequent diagnoses, such as, colorectal, prostate, breast, lung, kidney, pancreatic, and bladder cancer and melanoma, were identified. Moreover, in case of colorectal, lung, and prostate cancer, improvement in stage-specific 5-year relative survival was confirmed as statistically significant for all clinical stages. No diagnosis showed significant decrease in the 5-year relative survival. However, the 5year relative survival remained poor in patients with metastatic cancers at diagnosis, particularly in case of liver, pancreatic, lung, and oesophageal cancer. Conclusions: The cancer-specific outcomes in the Czech Republic are improving. Nevertheless, despite the overall significant improvement in 5-year relative survival of most of the cancer diagnoses, the high proportion of patients primarily diagnosed with metastatic cancer still represents a substantial challenge for prevention and early detection.

Links

MUNI/A/0828/2011, interní kód MU

Name: Matematické a statistické modely v hodnocení výsledků programů screeningu zhoubných nádorů (Acronym: SCREENMOD)

Investor: Masaryk University, Category A

Citovat

PAVLÍK, Tomáš, Ondřej MÁJEK, Tomáš BÜCHLER, Rostislav VYZULA, Jiří PETERA, Miroslav RYŠKA, Aleš RYŠKA, David CIBULA, Marek BABJUK, Jitka ABRAHAMOVÁ, Jiří VORLÍČEK, Jan MUŽÍK and Ladislav DUŠEK. Trends in stage-specific population-based survival of cancer patients in the Czech Republic in the period 2000-2008. Cancer epidemiology. Oxford: Elsevier, 2014, vol. 38, No 1, p. 28-34. ISSN 1877-7821. Available from: https://dx.doi.org/10.1016/j.canep.2013.11.002.

@article{1183317,
   author = {Pavlík, Tomáš and Májek, Ondřej and Büchler, Tomáš and Vyzula, Rostislav and Petera, Jiří and Ryška, Miroslav and Ryška, Aleš and Cibula, David and Babjuk, Marek and Abrahamová, Jitka and Vorlíček, Jiří and Mužík, Jan and Dušek, Ladislav},
   article_location = {Oxford},
   article_number = {1},
   doi = {http://dx.doi.org/10.1016/j.canep.2013.11.002},
   keywords = {Cancer; Population-based registry; Relative survival; Stage-specific analysis},
   language = {eng},
   issn = {1877-7821},
   journal = {Cancer epidemiology},
   title = {Trends in stage-specific population-based survival of cancer patients in the Czech Republic in the period 2000-2008},
   volume = {38},
   year = {2014}
}

TY  - JOUR
ID  - 1183317
AU  - Pavlík, Tomáš - Májek, Ondřej - Büchler, Tomáš - Vyzula, Rostislav - Petera, Jiří - Ryška, Miroslav - Ryška, Aleš - Cibula, David - Babjuk, Marek - Abrahamová, Jitka - Vorlíček, Jiří - Mužík, Jan - Dušek, Ladislav
PY  - 2014
TI  - Trends in stage-specific population-based survival of cancer patients in the Czech Republic in the period 2000-2008
JF  - Cancer epidemiology
VL  - 38
IS  - 1
SP  - 28-34
EP  - 28-34
PB  - Elsevier
SN  - 18777821
KW  - Cancer
KW  - Population-based registry
KW  - Relative survival
KW  - Stage-specific analysis
N2  - Background: The objective of this study was to assess trends in overall and in stage-specific 5-year relative survival rates of the Czech cancer patients between periods 2000-2004 and 2005-2008. Methods: All Czech cancer patients diagnosed between 1995 and 2008 were included in the analysis. Period analysis was employed to calculate 5-year relative survival for 21 cancers. Results: Significant improvements in crude 5-year relative survival for 14 of 21 assessed types of cancer, including the most frequent diagnoses, such as, colorectal, prostate, breast, lung, kidney, pancreatic, and bladder cancer and melanoma, were identified. Moreover, in case of colorectal, lung, and prostate cancer, improvement in stage-specific 5-year relative survival was confirmed as statistically significant for all clinical stages. No diagnosis showed significant decrease in the 5-year relative survival. However, the 5year relative survival remained poor in patients with metastatic cancers at diagnosis, particularly in case of liver, pancreatic, lung, and oesophageal cancer. Conclusions: The cancer-specific outcomes in the Czech Republic are improving. Nevertheless, despite the overall significant improvement in 5-year relative survival of most of the cancer diagnoses, the high proportion of patients primarily diagnosed with metastatic cancer still represents a substantial challenge for prevention and early detection.
ER  -

PAVLÍK, Tomáš, Ondřej MÁJEK, Tomáš BÜCHLER, Rostislav VYZULA, Jiří PETERA, Miroslav RYŠKA, Aleš RYŠKA, David CIBULA, Marek BABJUK, Jitka ABRAHAMOVÁ, Jiří VORLÍČEK, Jan MUŽÍK and Ladislav DUŠEK. Trends in stage-specific population-based survival of cancer patients in the Czech Republic in the period 2000-2008. \textit{Cancer epidemiology}. Oxford: Elsevier, 2014, vol.~38, No~1, p.~28-34. ISSN~1877-7821. Available from: https://dx.doi.org/10.1016/j.canep.2013.11.002.

Detailed Information on Publication Record